Publication Name	World Journal of Hepatology
Manuscript ID	13364
Country	Italy

Received	2014-08-20 08:28
Peer-Review Started	2014-08-20 09:34
To Make the First Decision	2014-09-16 11:07
Return for Revision	2014-09-20 21:38
Revised	2014-09-27 16:48
Second Decision	2015-01-08 16:45
Accepted by Journal Editor-in-Chief	2015-01-08 22:04
Accepted by Company Editor-in-Chief	2015-01-19 13:46
Articles in Press	2015-01-19 13:46
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-13 12:22
Publish the Manuscript Online	2015-04-19 17:46

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives
Manuscript Source	Invited Manuscript
All Author List	Cristina Mosconi, Alberta Cappelli, Cinzia Pettinato and Rita Golfieri
Funding Agency and Grant Number
Corresponding Author	Cristina Mosconi, MD, UO, Radiology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, vai Albertoni 15, 40138 Bologna, Italy. cristina.mosconi@aosp.bo.it
Key Words	Yttrium-90; Hepatocellular carcinoma; Radioembolization
Core Tip	Transarterial radioembolization (TARE) is a consolidated therapy for hepatocellular carcinoma. TARE is best indicated for both intermediate-stage patients (according to the Barcelona clinic liver cancer staging classification) who have lesions which respond poorly to chemoembolization due to multiple tumors or large tumor burden, and for locally advanced-stage patients with solitary tumors, and segmental or lobar portal vein tumor thrombosis. Moreover, emerging data have suggested the use of TARE in patients who are classified slightly beyond the Milan criteria regarding radical treatment for downstaging purposes. This review analyzes the best selection criteria for patients who really benefit from TARE.
Publish Date	2015-04-19 17:46
Citation	Mosconi C, Cappelli A, Pettinato C, Golfieri R. Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives. World J Hepatol 2015; 7(5): 738-752
URL	http://www.wjgnet.com/1948-5182/full/v7/i5/738.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i5.738

Full Article (PDF)	WJH-7-738.pdf
Full Article (Word)	WJH-7-738.doc
Manuscript File	13364-Review.docx
Answering Reviewers	13364-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13364-Conflict-of-interest statement.pdf
Copyright License Agreement	13364-Copyright assignment.pdf
Peer-review Report	13364-Peer review(s).pdf
Scientific Misconduct Check	13364-CrossCheck.jpg
Scientific Editor Work List	13364-Scientific editor work list.pdf